Standout Papers

WAF1, a potential mediator of p53 tumor suppression 1992 2026 2003 2014 7.2k
  1. WAF1, a potential mediator of p53 tumor suppression (1993)
    Wafik S. El‐Deiry, Takashi Tokino et al. Cell
  2. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia (1992)
    Wafik S. El‐Deiry, France Carrier et al. Cell
  3. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. (1994)
    Wafik S. El‐Deiry, J. Wade Harper et al. PubMed
  4. Targeting apoptosis in cancer therapy (2020)
    Benedito A. Carneiro, Wafik S. El‐Deiry Nature Reviews Clinical Oncology
  5. Definition of a consensus binding site for p53 (1992)
    Wafik S. El‐Deiry, Scott E. Kern et al. Nature Genetics
  6. Overview of cell death signaling pathways (2005)
    Zhaoyu Jin, Wafik S. El‐Deiry Cancer Biology & Therapy
  7. FADD: Essential for Embryo Development and Signaling from Some, But Not All, Inducers of Apoptosis (1998)
    Wen‐Chen Yeh, José Luís de la Pompa et al. Science
  8. TRAIL and apoptosis induction by TNF-family death receptors (2003)
    Shulin Wang, Wafik S. El‐Deiry Oncogene
  9. Regulation ofp53downstream genes (1998)
    Wafik S. El‐Deiry Seminars in Cancer Biology
  10. Acoustic separation of circulating tumor cells (2015)
    Peng Li, Zhangming Mao et al. Proceedings of the National Academy of Sciences
  11. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death (2005)
    Guido Kroemer, Wafik S. El‐Deiry et al. Cell Death and Differentiation
  12. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. (1995)
    Wafik S. El‐Deiry, Takashi Tokino et al. PubMed
  13. Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting (2021)
    Liz J. Hernández Borrero, Wafik S. El‐Deiry Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  14. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents. (1994)
    Saijun Fan, Wafik S. El‐Deiry et al. PubMed

Immediate Impact

23 by Nobel laureates 162 from Science/Nature 402 standout
Sub-graph 1 of 13

Citing Papers

Copper induces cell death by targeting lipoylated TCA cycle proteins
2022 StandoutScience
The biology and management of non-small cell lung cancer
2018 StandoutNature
2 intermediate papers

Works of Wafik S. El‐Deiry being referenced

The efficacy of larotrectinib (LOXO-101), a selective tropomyosin receptor kinase (TRK) inhibitor, in adult and pediatric TRK fusion cancers.
2017
The efficacy of larotrectinib (LOXO-101), a selective tropomyosin receptor kinase (TRK) inhibitor, in adult and pediatric TRK fusion cancers.
2017
and 4 more

Author Peers

Author Last Decade Papers Cites
Wafik S. El‐Deiry 23024 32596 9235 569 46.2k
David P. Lane 31996 37043 8635 606 57.0k
Moshe Oren 28528 34533 9746 323 48.3k
Karen H. Vousden 24148 34167 12175 239 48.4k
Scott W. Lowe 22670 49438 16688 324 68.3k
Charles J. Sherr 30272 38985 6856 270 57.5k
Isaiah J. Fidler 20990 21725 13490 496 47.8k
Gerry Melino 10870 21759 7046 612 36.2k
Carlos Cordon‐Cardo 22560 40955 12688 563 67.3k
Albert J. Fornace 12815 25494 7682 409 35.4k
Curtis C. Harris 21985 40543 24469 571 65.7k

All Works

Loading papers...

Rankless by CCL
2026